TOPIRAMATE

NDC 68462-370 · Glenmark Pharmaceuticals Inc., USA

Generic nametopiramate

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength150 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

68462-370-05 — 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-05)

68462-370-30 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-30)

68462-370-90 — 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68382-498 — topiramate, 68382-769 — Topiramate, 68382-863 — Topiramate, 68382-864 — Topiramate, 68462-108 — Topiramate, 68462-109 — Topiramate, 68462-110 — Topiramate, 68462-153 — Topiramate, 68462-218 — Topiramate, 68462-219 — Topiramate, 68462-371 — topiramate, 68462-372 — topiramate, 68462-373 — topiramate, 68462-374 — topiramate, 68788-4067 — topiramate, 68788-7351 — topiramate, 68788-7460 — topiramate, 68788-7468 — topiramate, 68788-7568 — topiramate, 68788-8817 — topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels